These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 35065987

  • 1. Efficacy of Bladder Ultrasound in Prediction of Resolution of Vesicoureteral Reflux After Endoscopic Subureteral Hyaluronic Acid/Dextranomer (Deflux) Injection.
    Aboutaleb H, Eldib DB, Farahat Y, Abouelgreed TA, Zanaty F.
    Urology; 2022 Jul; 165():299-304. PubMed ID: 35065987
    [Abstract] [Full Text] [Related]

  • 2. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children.
    Oswald J, Riccabona M, Lusuardi L, Bartsch G, Radmayr C.
    Urology; 2002 Nov; 60(5):894-7; discussion 898. PubMed ID: 12429323
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic Subureteral Injection for the Treatment of Vesicoureteral Reflux in Children: Polydimethylsiloxane (Macroplastique(R)) versus Dextranomer/Hyaluronic Acid Copolymer (Deflux(R)).
    Bae YD, Park MG, Oh MM, Moon du G.
    Korean J Urol; 2010 Feb; 51(2):128-31. PubMed ID: 20414426
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS, Altan M, Citamak B, Bozaci AC, Koni A, Tekgul S.
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [Abstract] [Full Text] [Related]

  • 5. The appearance of dextranomer-hyaluronic acid copolymer implants on ultrasound may predict resolution of vesicoureteral reflux after injection therapy.
    Park KJ, Jeon TY, Yoo SY, Kim JH, Eo H, Song KD.
    Clin Radiol; 2014 Sep; 69(9):939-44. PubMed ID: 24865315
    [Abstract] [Full Text] [Related]

  • 6. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.
    Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Stenberg A, Läckgren G.
    J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.
    Sheth KR, White JT, Stanasel I, Janzen N, Mittal A, Koh CJ, Austin PF, Roth DR, Tu DD, Gonzales ET, Ryan S, Jorgez C, Seth A.
    J Pediatr Urol; 2018 Dec; 14(6):554.e1-554.e6. PubMed ID: 30146426
    [Abstract] [Full Text] [Related]

  • 9. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?
    Chertin B, Mele E, Kocherov S, Zilber S, Gerocarni Nappo S, Capozza N.
    J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870
    [Abstract] [Full Text] [Related]

  • 10. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?
    Arlen AM, Scherz HC, Filimon E, Leong T, Kirsch AJ.
    J Pediatr Urol; 2015 Feb; 11(1):40.e1-5. PubMed ID: 25725613
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success.
    Lavelle MT, Conlin MJ, Skoog SJ.
    Urology; 2005 Mar; 65(3):564-7. PubMed ID: 15780377
    [Abstract] [Full Text] [Related]

  • 13. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
    Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E.
    J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
    [Abstract] [Full Text] [Related]

  • 14. Comparison of dextranomer/hyaluronic acid based bulking agents in the treatment of vesicoureteral reflux in children: Deflux versus Vurdex.
    Pogorelić Z, Gudelj K, Budimir D, Todorić J, Jukić M, Furlan D, Košuljandić Đ, Saraga M.
    Can J Urol; 2016 Jun; 23(3):8312-7. PubMed ID: 27347628
    [Abstract] [Full Text] [Related]

  • 15. Endoscopic treatment with Deflux for refluxing duplex systems.
    Rossini CJ, Moriarty KP, Courtney RA, Tashjian DB.
    J Laparoendosc Adv Surg Tech A; 2009 Oct; 19(5):679-82. PubMed ID: 19432527
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utility of an intra-operative cystogram with a simulated voiding phase after endoscopic treatment of vesicoureteral reflux.
    Perlmutter AE, Talug C, Darbandi SS, Morabito R, Tarry WF.
    W V Med J; 2008 Oct; 104(4):22-4. PubMed ID: 18646680
    [Abstract] [Full Text] [Related]

  • 20. [Long-term results after endoscopic subureteral injection for VUR using dextranomer/hyaluronic acid copolymer : a five years experience].
    Seibold J, Werther M, Sievert KD, Stenzl A.
    Urologe A; 2010 Apr; 49(4):536-9. PubMed ID: 20063087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.